Published in Nutr J on February 09, 2005
Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord (2007) 0.96
Common use of dietary supplements for bipolar disorder: a naturalistic, self-reported study. Int J Bipolar Disord (2015) 0.95
Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord (2010) 0.88
Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders. Clin Psychopharmacol Neurosci (2015) 0.84
Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids. J Psychosom Res (2013) 0.79
Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment. Bipolar Disord (2015) 0.76
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry (1999) 5.40
Omega-3 fatty acids. Am Fam Physician (2004) 2.46
Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr (2004) 2.03
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry (2002) 1.98
Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry (1998) 1.73
A clinical monitoring form for mood disorders. Bipolar Disord (2002) 1.66
A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry (2003) 1.46
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res (2001) 1.22
The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest (1996) 1.14
omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry (2003) 1.09
Behavioural and psychological syndromes in Alzheimer's disease. Int J Geriatr Psychiatry (2004) 1.06
Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids (2004) 1.01
Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry (2004) 0.98
Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr (2004) 0.94
An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot) [ISRCTN22569553]. Nutr J (2004) 0.88
[Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca]. Encephale (2002) 0.87
Food as medicine--cost-effective health care? The example of omega-3 fatty acids. Minn Med (2003) 0.81
Bioelectrical modulators and the cell membrane in psychiatric medicine. Psychopharmacol Bull (2001) 0.78
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. J Clin Psychiatry (2006) 1.48
Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43
Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry (2007) 1.26
The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol (2004) 1.04
Olanzapine attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull (2006) 0.91
An open prospective study of zonisamide in acute bipolar depression. J Clin Psychopharmacol (2006) 0.87
Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull (2006) 0.82
Correlates of functioning in bipolar disorder. Psychopharmacol Bull (2008) 0.82
The current understanding of lamotrigine as a mood stabilizer. J Clin Psychiatry (2004) 0.80
Bipolar spectrum disorder: a pilot study. Psychopathology (2004) 0.80
Interrater reliability and coding guide for nonpsychotic formal thought disorder. Percept Mot Skills (2006) 0.77
Modafinil: past, present and future. Expert Rev Neurother (2002) 0.76
Treatment of bipolar depression. CNS Spectr (2003) 0.76
Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial. J Clin Psychopharmacol (2015) 0.75
Desipramine toxicity with terbinafine. Am J Psychiatry (2002) 0.75